methylcellulose-based medium methocult gf h4434 (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
methylcellulose-based medium methocult gf h4434
Methylcellulose Based Medium Methocult Gf H4434, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methocult+gf+h4434/methocult/pm39179669-52-21-25
Average 90 stars, based on 1 article reviews
Methylcellulose Based Medium Methocult Gf H4434, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/methocult+gf+h4434/methocult/pm39179669-52-21-25
Average 90 stars, based on 1 article reviews
methylcellulose-based medium methocult gf h4434 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Fast recovery of platelet production in NOD/SCID mice after transplantation with ex vivo expansion of megakaryocyte from cord blood CD34+ cells. Article Snippet: CFU‐Mk assay: Totally, 1 × 104 CD34+ cells were seeded into 24‐well plates for Article Title: The landscape of RNA-chromatin interaction reveals small non-coding RNAs as essential mediators of leukemia maintenance Article Snippet: MethoCult H4230 and Labeling:Article Title: Treatment of brain damage using umbilical cord blood cells Article Snippet: FACS analysis using anti-CD34 and anti-CD133 antibodies (Miltenyi Biotec, Gladbach, Germany) labeled with phycoerythrin (PE) (Becton Dickinson, USA) of MACS-sorted cells showed that 90%±3% of the selected cells were positive for both CD34 and CD133 as shown in FIG. 1B. .. Then, cells labeled with 1 μg/mL bisbenzimide (Hoechst 33342; Sigma, USA), resuspended in 3004 Iscove's Modified Dulbecco's Medium (Gibco/Invitrogen, UK) plus 2% FBS (Hyclone, Road Logan, Utah) were mixed with 3 ml Modification:Article Title: Treatment of brain damage using umbilical cord blood cells Article Snippet: FACS analysis using anti-CD34 and anti-CD133 antibodies (Miltenyi Biotec, Gladbach, Germany) labeled with phycoerythrin (PE) (Becton Dickinson, USA) of MACS-sorted cells showed that 90%±3% of the selected cells were positive for both CD34 and CD133 as shown in FIG. 1B. .. Then, cells labeled with 1 μg/mL bisbenzimide (Hoechst 33342; Sigma, USA), resuspended in 3004 Iscove's Modified Dulbecco's Medium (Gibco/Invitrogen, UK) plus 2% FBS (Hyclone, Road Logan, Utah) were mixed with 3 ml Recombinant:Article Title: Treatment of brain damage using umbilical cord blood cells Article Snippet: FACS analysis using anti-CD34 and anti-CD133 antibodies (Miltenyi Biotec, Gladbach, Germany) labeled with phycoerythrin (PE) (Becton Dickinson, USA) of MACS-sorted cells showed that 90%±3% of the selected cells were positive for both CD34 and CD133 as shown in FIG. 1B. .. Then, cells labeled with 1 μg/mL bisbenzimide (Hoechst 33342; Sigma, USA), resuspended in 3004 Iscove's Modified Dulbecco's Medium (Gibco/Invitrogen, UK) plus 2% FBS (Hyclone, Road Logan, Utah) were mixed with 3 ml Transplantation Assay:Article Title: Treatment of brain damage using umbilical cord blood cells Article Snippet: FACS analysis using anti-CD34 and anti-CD133 antibodies (Miltenyi Biotec, Gladbach, Germany) labeled with phycoerythrin (PE) (Becton Dickinson, USA) of MACS-sorted cells showed that 90%±3% of the selected cells were positive for both CD34 and CD133 as shown in FIG. 1B. .. Then, cells labeled with 1 μg/mL bisbenzimide (Hoechst 33342; Sigma, USA), resuspended in 3004 Iscove's Modified Dulbecco's Medium (Gibco/Invitrogen, UK) plus 2% FBS (Hyclone, Road Logan, Utah) were mixed with 3 ml |